Tpharm.info


What is zaleplon





Zaleplon oral Uses, Side Effects, Interactions, Pictures, Warnings

5/7/2014
06:59 | Author: Brandon Powell

What is zaleplon
Zaleplon oral Uses, Side Effects, Interactions, Pictures, Warnings

Find patient medical information for zaleplon oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Subscribe to the Men's Health newsletter for the latest on disease prevention, fitness, sex, nutrition, and more from WebMD.

WebMD Allergy App for iPhone Featured Content.

Take this medication by mouth as directed by your doctor. Zaleplon works very quickly, so it is important to take it just before or when you get into bed. Zaleplon should not be used for naps or short sleep periods of less than 4 hours because this may increase your risk of side effects such as memory loss or drowsiness. Your doctor will work with you to find the smallest dose that works for you.

You may feel anxious or have trouble falling asleep in the first day or two after stopping this medication (rebound insomnia).

Comments (1)Read more



Sonata (Zaleplon) Patient Information Side Effects and Drug Images

11/16/2014
02:22 | Author: David Perry

What is zaleplon
Sonata (Zaleplon) Patient Information Side Effects and Drug Images

Pictures of Sonata (Zaleplon), drug imprint information, side effects for the patient.

Zaleplon is a sedative, also called a hypnotic. It affects chemicals in your brain that may become unbalanced and cause sleep problems (insomnia).

The top third of sleeping-pill users had a 5.3-fold higher death risk.".

You are encouraged to report negative side effects of prescription drugs to the FDA.

Comments (2)Read more

Zaleplon medical facts from

11/15/2014
12:17 | Author: Nick Jenkins

What is zaleplon
Zaleplon medical facts from

Physician reviewed zaleplon patient information - includes zaleplon description, dosage and directions.

To make sure zaleplon is safe for you, l your doctor if you have ever been addicted to drugs or alcohol.

a history of drug or alcohol addiction.

Approval History Calendar Drug history at FDA.

liver or kidney disease;

Pregnancy Category C Risk cannot be ruled out.

Data sources include Micromedex (updated Sep 26th, 2014), Cerner Multum (updated Oct 16th, 2014), Wolters Kluwer (updated Oct 9th, 2014) and others. To view content sources and attributions, refer to our editorial policy.

FDA pregnancy category C.

Comments (3)Read more

Zaleplon MedlinePlus Drug Information - National Library of Medicine

9/14/2014
02:24 | Author: Emma Coleman

What is zaleplon
Zaleplon MedlinePlus Drug Information - National Library of Medicine

Zaleplon is used to treat insomnia (difficulty falling asleep). Zaleplon does not help you to stay asleep longer or decrease the number of times.

difficulty breathing or swallowing.

Last Revised - 10/01/2008.

Zaleplon may cause other side effects. l your doctor if you experience any unusual problems while you are taking this medication.

Zaleplon comes as a capsule to take by mouth. It is usually taken as needed at bedtime or after trying unsuccessfully to fall asleep. Do not take zaleplon with or shortly after a heavy, high-fat meal. Zaleplon may not work well if it is taken with high fat foods. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.

Comments (4)Read more

Zaleplon - FDA prescribing information, side effects and uses

7/13/2014
04:55 | Author: Kayla Henderson

What is zaleplon
Zaleplon - FDA prescribing information, side effects and uses

Zaleplon official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

The potential for other withdrawal phenomena was also assessed in 14- to 28-night studies, including both the sleep laboratory studies and the outpatient studies, and in open-label studies of 6- and 12-month durations. The Benzodiazepine Withdrawal Symptom Questionnaire was used in several of these studies, both at baseline and then during days 1 and 2 following discontinuation. Withdrawal was operationally defined as the emergence of 3 or more new symptoms after discontinuation. Zaleplon was not distinguishable from placebo at doses of 5 mg, 10 mg, or 20 mg on this measure, nor was Zaleplon distinguishable from placebo on spontaneously reported withdrawal-emergent adverse events.

Comments (5)Read more